PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
ESG score 80-90% of TGTX's 66.04. Walter Schloss would scrutinize governance quality and regulatory exposure.
59.54
Environmental score 1.1-1.2x TGTX's 50.00. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
58.66
Social score below 80% of TGTX's 86.11. Jim Chanos would check for potential social license and litigation risks.
57.40
Governance score 90-95% of TGTX's 62.02. Bill Ackman would demand clear governance improvement catalysts.